Back

American College of Clinical Pharmacology

  • Abacavir
  • Dolutegravir
  • HIV Infections
  • Lamivudine

ACCP Journal CE January 2025 – A Model-Based Approach Supporting Abacavir/Dolutegravir/Lamivudine Fixed-Dose Combination Approval in Children Living with HIV-1

ACCP Journal CE January 2025 – A Model-Based Approach Supporting Abacavir/Dolutegravir/Lamivudine Fixed-Dose Combination Approval in Children Living with HIV-1

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1 credit

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

no cost to ACCP MembersFree
$75/calendar year to Non-members$75

Listed by the provider · ce.accp1.org

  • Enduring / On-demand
  • Credit · Up to 1 credit
  • Free for members · $75 standard
  • Released
    Jan 1, 2025
  • Last day to claim credit
    Jan 2, 2028 1 year left